Andrea Apolo
Bladder cancer specialist and leader within the Center for Cancer Research at the NCI, serving as head of the Bladder Cancer Section and acting deputy chief of the Genitourinary Malignancies Branch, providing expert commentary on ASCO GU symposium data.
Best podcasts with Andrea Apolo
Ranked by the Snipd community
Mar 5, 2026 • 20min
Highlights From the 2026 ASCO GU Cancers Symposium
Andrea Apolo, bladder cancer specialist and NCI leader, gives expert commentary on GU cancer advances. They cover KEYNOTE-B15 and EV304/EV303 results for perioperative bladder cancer. Discussions include BCG strain findings, new RCC therapies like belzutifan combinations, adjuvant immunotherapy signals, and improved outcomes in prostate cancer with enzalutamide plus radium-223.
